Answers are grounded in this paper and cite their sources.
This case-control study of US children examines vaccine effectiveness rates of a messenger RNA vaccine during the 2023-2024 respiratory virus season.
No takes yet. Share an insight, caveat, or question.
Tartof et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: